Clincosm LogoSign in Get a demo

Triple Negative Breast Cancer

Showing NaN - NaN of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Triple Negative Breast Cancer
  • +6 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
  • +1 more
Mar 8, 2023

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

Recruiting
  • Ovarian Cancer
  • +8 more
  • Scottsdale, Arizona
  • +11 more
Jan 31, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Metastatic Breast Cancer
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)

Recruiting
  • Breast Cancer
  • +5 more
  • MRI
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 9, 2022

Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Radiation Therapy Boost
  • +6 more
  • Washington, District of Columbia
  • +8 more
Dec 5, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

Recruiting
  • Advanced Solid Tumor Historically Known for High EphA2 Expression
  • +6 more
  • Encinitas, California
  • +27 more
Aug 17, 2022

Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer Trial in Worldwide (PDR001)

Completed
Has Results
  • Melanoma
  • +4 more
  • PDR001
  • Baltimore, Maryland
  • +40 more
Aug 2, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Hormone Receptor Positive Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in Japan, United States (Datopotamab

Recruiting
  • Hormone Receptor Positive Breast Cancer
  • +2 more
  • Datopotamab Deruxtecan (Dato-DXd)
  • Los Angeles, California
  • +13 more
Jun 21, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)

Recruiting
  • Breast Cancer
  • +3 more
  • San Francisco, California
  • +8 more
May 25, 2022

Tumor Malignant, Epithelial Ovarian Cancer, Triple Negative Breast Cancer Trial in United States (XL102, Fulvestrant,

Recruiting
  • Neoplasm Malignant
  • +4 more
  • Atlanta, Georgia
  • +4 more
Apr 19, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in Washington, Boston, Chapel Hill (Niraparib, Dostarlimab, Radiation

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +2 more
Apr 13, 2022

Solid Tumors, Colorectal Cancer, Breast Cancer Trial in Canada, United States (LY2880070, Gemcitabine)

Completed
  • Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +8 more
Mar 18, 2022

Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Metastatic Cancer Trial in United States (CMP-001, cemiplimab-rwlc)

Recruiting
  • Merkel Cell Carcinoma
  • +4 more
  • Jacksonville, Florida
  • +6 more
Feb 24, 2022

Triple Negative Breast Cancer Trial in United States (Cisplatin, Paclitaxel)

Active, not recruiting
Has Results
  • Triple Negative Breast Cancer
  • Birmingham, Alabama
  • +19 more
Feb 14, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Triple Negative Breast Cancer, Residual Disease Trial in Boston (Niraparib, Radiation Therapy)

Recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • Boston, Massachusetts
  • +1 more
Oct 27, 2021

Invasive Breast Cancer, Triple Negative Breast Cancer, ER-Negative Breast Cancer Trial in Boston, Danvers, Newton (Sacituzumab

Active, not recruiting
  • Invasive Breast Cancer
  • +4 more
  • Boston, Massachusetts
  • +4 more
Oct 25, 2021

Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

Completed
Has Results
  • Gastric Adenocarcinoma
  • +15 more
  • Sacituzumab Govitecan-hziy (SG)
  • Aurora, Colorado
  • +11 more
Aug 10, 2021

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021